Human immunodeficiency virus type-1 Tat protein induces secretory leukocyte protease inhibitor expression in African green monkey but not human cells

被引:1
|
作者
Ozdemir, Selcuk [1 ,2 ]
Sengez, Burcu [1 ,3 ]
Arslanoglu, Alper [1 ]
机构
[1] Izmir Inst Technol, Dept Mol Biol & Genet, Fac Sci, Izmir, Turkey
[2] Ataturk Univ, Div Zootech & Anim Nutr, Dept Genet, Fac Vet Med, Erzurum, Turkey
[3] Izmir Biomed & Genome Ctr, Dokuz Eylul Univ Hlth Campus, Izmir, Turkey
关键词
African green monkey; HIV-1; tat; Secretory leukocyte protease inhibitor; Anti-HIV-1; activity; IMMUNE ACTIVATION; GENE-EXPRESSION; HIV-1; INFECTION; SLPI; ELAFIN; PREDICTS; AIDS;
D O I
10.1007/s11262-020-01731-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
African monkeys are resistant to HIV-1 infection due to intrinsic restriction mechanisms found in their cells. However, although they can be infected by monkey-adapted modified HIV-1 particles that are designed to overcome known restriction factors, virus numbers drop to undetectable levels in immunocompetent animals. These results indicate the possibility of the presence of yet unidentified factor(s) that restrict HIV-1 in old-world monkey (OWM) cells after integration of the viral genome into the host cell chromosome. In the light of these findings, we hypothesized that OWMs might have evolved resistance mechanism(s) against HIV-1 by switching specific gene(s) on in response to the synthesis of viral proteins in infected cells. In an attempt to mimic post-infection status, we expressed HIV-1 Tat gene in African green monkey cells and compared the whole proteome with normal cells and identified secretory leukocyte protease inhibitor (SLPI), a protein with known extracellular anti-HIV-1 activity, as an over-expressed protein in the presence of HIV-1 Tat protein by 2D-PAGE and mass spectrometry analysis. We also showed that overexpression of SLPI in the presence of HIV-1 Tat was specific to monkey cells. Our results also suggest that SLPI had a previously undiscovered intracellular anti-HIV activity in addition to its extracellular activity.
引用
收藏
页码:182 / 193
页数:12
相关论文
共 50 条
  • [31] GENERATION AND CHARACTERIZATION OF INFECTIOUS CHIMERIC CLONES BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND SIMIAN IMMUNODEFICIENCY VIRUS FROM AN AFRICAN-GREEN MONKEY
    SHIBATA, R
    SAKAI, H
    KIYOMASU, T
    ISHIMOTO, A
    HAYAMI, M
    ADACHI, A
    JOURNAL OF VIROLOGY, 1990, 64 (12) : 5861 - 5868
  • [32] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT GENE ENHANCES HUMAN PAPILLOMAVIRUS EARLY GENE-EXPRESSION
    TORNESELLO, ML
    BUONAGURO, FM
    BETHGIRALDO, E
    GIRALDO, G
    INTERVIROLOGY, 1993, 36 (02) : 57 - 64
  • [33] Human immunodeficiency virus type I stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity
    Jana, NK
    Gray, LR
    Shugars, DC
    JOURNAL OF VIROLOGY, 2005, 79 (10) : 6432 - 6440
  • [34] Functions of Tat: the versatile protein of human immunodeficiency virus type 1
    Romani, Bizhan
    Engelbrecht, Susan
    Glashoff, Richard H.
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1 - 12
  • [35] CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES TO THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    BRAKE, DA
    GOUDSMIT, J
    KRONE, WJA
    SCHAMMEL, P
    APPLEBY, N
    MELOEN, RH
    DEBOUCK, C
    JOURNAL OF VIROLOGY, 1990, 64 (02) : 962 - 965
  • [36] Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat
    D'Aversa, TG
    Yu, KOA
    Berman, JW
    JOURNAL OF NEUROVIROLOGY, 2004, 10 (02) : 86 - 97
  • [37] Amprenavir: A new human immunodeficiency virus type 1 protease inhibitor
    Fung, HB
    Kirschenbaum, HL
    Hameed, R
    CLINICAL THERAPEUTICS, 2000, 22 (05) : 549 - 572
  • [38] Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat
    Teresa G. D’Aversa
    Karl O. A. Yu
    Joan W. Berman
    Journal of NeuroVirology, 2004, 10 : 86 - 97
  • [39] CHARACTERIZATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANT WITH REDUCED SENSITIVITY TO AN AMINODIOL PROTEASE INHIBITOR
    PATICK, AK
    ROSE, R
    GREYTOK, J
    BECHTOLD, CM
    HERMSMEIER, MA
    CHEN, PT
    BARRISH, JC
    ZAHLER, R
    COLONNO, RJ
    LIN, PF
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2148 - 2152
  • [40] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A TAT-ACTIVATED, TRANSDUCED INTERFERON GENE - TARGETED EXPRESSION TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CELLS
    SU, Y
    POPIK, W
    PITHA, PM
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 110 - 121